Elio Adib (@adib_elio) 's Twitter Profile
Elio Adib

@adib_elio

PGY-3 Resident @HarvardRadOnc | @BrighamMedRes '23 @AUB_FM '19 | Cancer Epigenomics | views = own

ID: 1075650377243131904

linkhttps://scholar.google.com/citations?user=jCDc42EAAAAJ&hl=en calendar_today20-12-2018 07:13:29

518 Tweet

1,1K Takipçi

906 Takip Edilen

Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨Pelvic lymph node XRT improves survival for young men w/ #prostatecancer🚨 Journal of Clinical Oncology ASCO 🗓️Median f/u 10.2 years, n=350 ☢️For men <65 years WPRT improved ✅OS: HR 0.33 ✅PCSM: HR 0.17 👉Post-hoc analysis of an RCT from 2005!!! Before any PSMA PET

🚨Pelvic lymph node XRT improves survival for young men w/ #prostatecancer🚨

<a href="/JCO_ASCO/">Journal of Clinical Oncology</a> <a href="/ASCO/">ASCO</a> 

🗓️Median f/u 10.2 years, n=350

☢️For men &lt;65 years WPRT improved
✅OS: HR 0.33
✅PCSM: HR 0.17

👉Post-hoc analysis of an RCT from 2005!!! Before any PSMA PET
Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

Make sense. Radiation hardens the pancreas. Sutures hold better. 👇🏼👇🏼 Preop chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy ⁦SURGERY Journal⁩ ⁦Marc Besselink⁩ surgjournal.com/article/S0039-…

Corinne Faivre-Finn 💙 (@finn_corinne) 's Twitter Profile Photo

🔥 off the press JTO & JTO CRR - EORTC LungTech trial 8×7.5Gy in central NSCLC At 3-year ▶️freedom from local progression 81.5% ▶️distant progression 29.8% ▶️SBRT-related acute and late AEs ≥ G3 in 6.5% and 19.4 % jto.org/article/S1556-…

Elio Adib (@adib_elio) 's Twitter Profile Photo

🚨⚠️ #Match2025/#ERAS2025 applicants: happy to help people, especially #IMG on #Medtwitter again this year with applications, review of CVs, personal statements, etc. (free of charge of course!)

Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

Enticing results reported in the TORCH study at #ASCO24 and just published in Journal of Clinical Oncology 📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B Full paper 🔗: ascopubs.org/doi/abs/10.120…

Enticing results reported in the TORCH study at #ASCO24 and just published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> 

📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B  

Full paper 🔗: ascopubs.org/doi/abs/10.120…
PCF Science (@pcf_science) 's Twitter Profile Photo

PUBLISHED! The 30th Annual Prostate Cancer Foundation Scientific Retreat Report, which summarizes the cutting-edge research in #ProstateCancer & other fields presented at the 2023 Prostate Cancer Foundation Retreat. #PCFRetreat23 Howard Soule Andrea Miyahira onlinelibrary.wiley.com/doi/epdf/10.10…

PUBLISHED! The 30th Annual Prostate Cancer Foundation Scientific Retreat Report, which summarizes the cutting-edge research in #ProstateCancer &amp; other fields presented at the 2023 <a href="/PCFnews/">Prostate Cancer Foundation</a> Retreat. #PCFRetreat23

<a href="/soulehoward1/">Howard Soule</a> <a href="/AndreaMiyahira/">Andrea Miyahira</a>
onlinelibrary.wiley.com/doi/epdf/10.10…
Erman Akkus (@erman_akkus) 's Twitter Profile Photo

🫁🧠Should up-front SRS be added to TKI in brain metastatic EGFR/ALK+ NSCLC❓ Journal of Clinical Oncology ✅Improves time-to-CNS progression HR: 0.63 (0.42 to 0.96), P = .033 ❌No difference in OS 🤔More than 20% of patients had >11 brain metastases 👉doi.org/10.1200/JCO.23… ASCO JCO Oncology Practice

🫁🧠Should up-front SRS be added to TKI in brain metastatic EGFR/ALK+ NSCLC❓
<a href="/JCO_ASCO/">Journal of Clinical Oncology</a> 

✅Improves time-to-CNS progression
HR: 0.63 (0.42 to 0.96), P = .033
❌No difference in OS

🤔More than 20% of patients had &gt;11 brain metastases

👉doi.org/10.1200/JCO.23…

<a href="/ASCO/">ASCO</a> <a href="/JCOOP_ASCO/">JCO Oncology Practice</a>
Harvard Radiation Oncology Residency Program (@harvardradonc) 's Twitter Profile Photo

For all #MedStudents applying for #RadOnc ☢️ this #Match2025 (or just curious about rad onc in general), we have an opportunity for you learn more about our program. Harvard Radiation Oncology Residency Program Sign up today! forms.gle/rd5pb5X8DYKcZt… #ERAS #MedTwitter #MedEd

For all #MedStudents applying for #RadOnc ☢️ this #Match2025 (or just curious about rad onc in general), we have an opportunity for you learn more about our program. <a href="/HarvardRadOnc/">Harvard Radiation Oncology Residency Program</a> Sign up today! forms.gle/rd5pb5X8DYKcZt… #ERAS #MedTwitter #MedEd
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Online Now: Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial dlvr.it/TBMv6T

Online Now: Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial dlvr.it/TBMv6T
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

Online First: Adaptive #radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell #lungcancer, according to [18F]FDG-PET uptake (RTEP7–IFCT-1402): a multicentre, randomised, controlled, phase 2 trial thelancet.com/journals/lanon…

Harvard Radiation Oncology Residency Program (@harvardradonc) 's Twitter Profile Photo

Slots are still open for our Aug 20th meet & greet session! Registration for the Aug 20th session will close tomorrow at 3 PM EST. You can still sign up for our Aug 28th session. We look forward to meeting you! forms.gle/JnVU8sMxEfXnir… #ERAS #MedTwitter #MedEd #Match2025

Harvard Radiation Oncology Residency Program (@harvardradonc) 's Twitter Profile Photo

What questions do you have for our residency program? Join us tomorrow for a virtual open house. Registration will close tomorrow at 3 PM EST. forms.gle/QpQTyUv6uAAq7Z… #Match2025 #ERAS2025 #RadOnc #MedEd #MedTwitter

What questions do you have for our residency program? Join us tomorrow for a virtual open house. Registration will close tomorrow at 3 PM EST. forms.gle/QpQTyUv6uAAq7Z… #Match2025 #ERAS2025 #RadOnc #MedEd #MedTwitter
كريستيان (@crsadb) 's Twitter Profile Photo

I'm looking to hire a junior AI engineer based in Beirut for a US-based enterprise software company. Must have experience building RAG systems, ideally with Langchain. If you fit the bill, please shoot your resume over to [email protected] with the subject line

كريستيان (@crsadb) 's Twitter Profile Photo

Do I know any US-based front end engineers who would be interested in temporary contract work? I’m building a very cool “reporting-as-a-service” application for a professional services client and need a hand with UI building. Stack is Django / React. Please do not apply if

Jacob Berchuck (@jberchuck) 's Twitter Profile Photo

🚀 Excited to share that I’ve joined Emory School of Medicine & Winship Cancer Institute of Emory University to launch The Berchuck Lab. Our research is focused on using liquid biopsy to improve outcomes for people living with cancer. We’re hiring for several key roles! Learn more & apply: theberchucklab.org

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman, the new David Goldstein Chair Dana-Farber. The Chair will focus on many aspects of Kidney Cancer Research Dana-Farber Lank Center for Genitourinary Oncology

A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman, the new David Goldstein Chair <a href="/DanaFarber/">Dana-Farber</a>. The Chair will focus on many aspects of Kidney Cancer Research <a href="/DanaFarber_GU/">Dana-Farber Lank Center for Genitourinary Oncology</a>